Form 4: Verona Pharma Executive Kathleen Rickard Reports Share Withholding for Tax Obligations
SEC Form 4 Filing
Kathleen A. Rickard, Chief Medical Officer of Verona Pharma plc, reports the withholding of ordinary shares to cover tax obligations related to vesting restricted share units.
Summary
- Kathleen A. Rickard, Chief Medical Officer of Verona Pharma plc, filed a Form 4 on August 5, 2024, reporting a transaction that occurred on August 1, 2024.
- The transaction involved the withholding of 106,232 ordinary shares to satisfy tax withholding obligations related to the vesting of previously reported Restricted Share Units.
- The price per share was $2.8325, calculated from the closing price of Verona Pharma's American Depositary Shares (ADSs) on July 31, 2024, divided by eight, as each ADS represents eight ordinary shares.
- Following the transaction, Rickard beneficially owns 2,515,320 ordinary shares, including shares underlying Restricted Share Units and ADSs.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing related to tax obligations, so it has a neutral sentiment. It doesn't indicate any positive or negative developments for the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for company insiders in the US, ensuring transparency in the market.
- Similar filings are expected from executives at comparable pharmaceutical companies like AstraZeneca, GlaxoSmithKline, or Novartis when they have transactions involving company stock.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a standard procedure for covering tax obligations related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 2024-05-23 | Date of execution of the Power of Attorney. |
| 2024-07-31 | Date used to calculate the price per share for the tax withholding. |
| 2024-08-01 | Date of the transaction involving the withholding of shares. |
| 2024-08-05 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.